ETIHX
Price
$41.14
Change
+$1.05 (+2.62%)
Updated
Sep 8 closing price
Net Assets
1.33B
FBTAX
Price
$31.26
Change
+$0.55 (+1.79%)
Updated
Sep 5 closing price
Net Assets
1.46B
Interact to see
Advertisement

ETIHX vs FBTAX

Header iconETIHX vs FBTAX Comparison
Open Charts ETIHX vs FBTAXBanner chart's image
Eventide Healthcare & Life Sciences I
Price$41.14
Change+$1.05 (+2.62%)
VolumeN/A
Net Assets1.33B
Fidelity Advisor Biotechnology A
Price$31.26
Change+$0.55 (+1.79%)
VolumeN/A
Net Assets1.46B
ETIHX vs FBTAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ETIHX vs. FBTAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETIHX is a StrongBuy and FBTAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.46B vs. ETIHX (1.33B). FBTAX pays higher dividends than ETIHX: FBTAX (2.59) vs ETIHX (0.00). ETIHX was incepted earlier than FBTAX: ETIHX (13 years) vs FBTAX (25 years). ETIHX (1.32) is less costly to investors than FBTAX (0.96). FBTAX (73.00) and ETIHX (71.00) have comparable annual turnover. FBTAX has a lower initial minimum investment than ETIHX: FBTAX (0) vs ETIHX (100000). ETIHX annual gain was more profitable for investors over the last year : 11.32 vs. FBTAX (-2.11). FBTAX return over 5 years is better than : 8.83 vs. ETIHX (-3.24).
ETIHXFBTAXETIHX / FBTAX
Total Expense Ratio1.320.96138%
Annual Report Gross Expense Ratio1.320.96138%
Fund Existence13 years25 years-
Gain YTD22.06914.884148%
Front LoadN/A6%-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B1.46B91%
Annual Yield % from dividends0.002.59-
Returns for 1 year11.32-2.11-537%
Returns for 3 years29.0538.3376%
Returns for 5 years-3.248.83-37%
Returns for 10 years67.9012.49544%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEOVF0.13N/A
+3.89%
SERNOVA BIOTHERAPEUTICS INC.
WXXWY9.350.19
+2.07%
Wuxi Biologics (Cayman) Inc
BWEL507.000.75
+0.15%
Boswell (J.G.) Co.
HAPVD10.01N/A
N/A
HAPVIDA PARTICIPACOES E INVESTIMENTOS SA
AXVEF0.18N/A
N/A
CDN MAVERICK CAP CORP.